A review of senescence biology argues that canonical markers developed in dividing peripheral cells do not reliably identify senescence-like states in post-mitotic neurons, where phenotypes vary by cell type, stressor, and experimental context. The authors propose multimarker, neuron-specific criteria to establish whether senescent neural cells causally contribute to Alzheimer's and Parkinson's pathology. Accurate definition matters because senolytic strategies that extend healthspan in peripheral tissues are already being extended to the brain.
Key Points
- No single marker defines senescence in post-mitotic neurons
- Senescent phenotypes vary by cell type, stressor, and context
- Neural senescence involves SASP-like signaling and altered glial interactions
Longevity Analysis
Senescent cell accumulation drives chronic low-grade inflammation and tissue decline throughout the body, and their selective clearance improves healthspan in peripheral tissues. Extending that logic to the brain requires correctly reading the signal first: neurons that cannot divide express damage and secretory phenotypes differently than replicating cells, and misidentification risks both false targets and missed ones. For anyone considering senolytic approaches, the discipline lies in distinguishing genuine cellular exhaustion from stress-adapted states that still support cognition, immune surveillance in neural tissue, and the regenerative capacity of surrounding glia.
Original published by Wiley Aging Cell, by Miraj Ud Din Momand, Kristina Macova, Dominika Fricova .